Peritonitis is the established term for infective inflammation of the peritoneum, whereas serositis generally refers to aseptic inflammation of a serous cavity, including the peritoneum. Serositis may be metabolic, viral, autoimmune, drug induced, genetic, allergic, granulomatous, or due to chemical antiseptics (eg, formic acid or chlorhexidine). 1 In our gynecological department, over a 12-month interval, 4 patients (aged 30, 30, 30, and 31 years) had serious abdominal complications after laparotomy. Investigations mainly based on the patient's records suggested that the antiseptic solution used during the surgeries caused the peritonitis.
CASES
All 4 laparotomies were performed through Pfannenstiel incisions, 2 for resection of ovarian cysts and 2 for myomectomies. Otherwise, all operations and postoperative periods were uneventful except in the 14th or 15th postoperative day, when the patients reported abdominal distension, pain, and discomfort and were readmitted to our intensive care unit. In all 4 cases massive abdominal effusion was diagnosed, the sediment of the ascites specimen was contained in red blood cells, and mesothelial cells were absent. Inflammatory serum markers were slightly elevated with predominance of neutrophil leukocytes. Serum immunologic markers excluded the possibility of systemic lupus erythematosus and bacterial or viral infections, including human parvovirus. Even although more than 1,000 mL fluid was drained, it reaccumulated and necessitated repeated drainages in the following 6 -8 days. Peritoneal effusion was resistant to the administration of steroids. Prophylactic antibiotics and intravenous albumin infusion were administered. The abdominal effusions completely disappeared after 2 or 3 weeks, except in case 3.
In case 3 the massive ascites appeared resistant to therapy and a unilateral pleural effusion occurred. The patient experienced frequent diarrhea. After pleural drainage, a repeat laparotomy was performed. The abdominal cavity contained 3000 mL blood-tinged ascites and no foreign body was found. A hysterectomy was performed.
The histologic examination of the peritoneal biopsy obtained during the repeat laparotomy of case 3 showed an appearance of fibrinoexudative serositis. Mesothelium was absent, and the outer layers of the peritoneal stroma contained fibrin. The collagen was pale-staining and the matrix edematous. There was a light chronic inflammatory infiltrate. The ascites reaccumulated on the second postoperative day and disappeared 2 weeks later after repeated drainages.
To find the etiologic origin in our 4 patients, we looked for similarities in their records. All women had unremarkable medical histories. All were young, and all operations were conservative procedures with intraoperative lavage without postoperative drainage. In our department, 8 -10 laparotomies are performed every day; these 5 operations were performed out in different operating rooms by different personnel except for 1 person. Ten instrument nurses are on staff, but the same person performed the instrumentation in these 5 operations.
In our department's routine preoperative practice, undiluted Octenisept solution (Schuelke & Mayr, Germany, Norderstedt) containing 0.1% octenidine dihydrochloride and 2% phenoxyethanol is used for disinfection of the vagina and physiologic saline for the lavage of the abdominal cavity. Contrary to the common practice, in these 5 operations the intraabdominal lavage was performed using Octenisept diluted in a ratio of 1:4 with saline solution. The nurse said that she had used this diluted Octenisept solution for intraperitoneal lavage during these 12 months, for a total of 44 laparotomies (12 conservative adnexal operations or myomectomies and 32 simple or radical hysterectomies), including the 5 described operations.
COMMENT
Based on our investigation, we believe that the Octenisept solution played a role in the tissue toxicity that caused the chemical serositis with effusion. Serositis had not developed in the other 8 cases in which Octenisept was used for lavage, so an individual susceptibility may contribute to the development of peritoneal lesion. In the conservative operations, the vagina was not opened; therefore, the antiseptic solution could not leak through the drainage with Pezzer catheter. In 31 hysterectomies, no affected case was found. (In the patient who had a repeat laparotomy ͓case 3͔, peritoneal mesothelium had already been damaged at the time of hysterectomy.)
Recently Kalteis et al 2 determined the tissue toxicity of different antiseptics used for disinfection of skin and for lavage and measured the irritation score and the irritation threshold for each substance. They found the most severe tissue toxicity for chlorhexidine digluconate 0.5%. Irritating values were found for Dibromol, Octenisept, and 2-propanol 6%. The tissue compatibility of Lavasept 0.2% and hydrogen peroxide was much better than the other tested substances.
With focus on the literature and our investigation we have stopped the use of Octenisept in any dilution for intraabdominal lavage in our department. (In the official instructions, Octenisept is offered in 1:4 dilution with twice distilled water for intraperitoneal lavage but is not recommended for repeated and continuous use.) We routinely use physiologic saline and, in septic cases, hydrogen peroxide, because unusual cases were encountered. During the last 9 months, no similar postoperative ascites have occurred in our department.
BACKGROUND:
Vulvovaginal lichen planus is an inflammatory dermatosis that can progress to an erosive form with scarring of the vulva, resorption of the labia minora, vaginal synechiae, and vaginal obliteration secondary to desquamative vaginitis. Traditionally, conservative medical therapy has consisted of topical corticosteroids and immunosuppressants.
CASE:
A 61-year-old woman with a history of refractory erosive vulvovaginal lichen planus presented with complete obliteration of the vaginal vault. The patient failed both medical and conservative surgical management and desired definitive management. After performing a skinning vulvectomy and simple vaginectomy, acellular dermal graft was used for grafting the vulva and creating a neovagina. Lichen planus is a relatively common inflammatory dermatosis. Patients typically present with cutaneous lesions, often found on the flexor surfaces of the extremities and the trunk, as well as with mucosal lesions affecting the buccal or gingival mucosa, vulvar vestibule, and vagina. The disorder is characterized by the presence of small polygonal violaceous, papules on the skin, and reticulated, gray lacy-patterned lesions on mucosal membranes, and it represents a cell-mediated immune response of unknown origin. 1 Erosive vaginal lichen planus represents a severe form of the disease, in which an intense inflammatory reaction completely erodes the vaginal epithelium resulting in a desquamative vaginitis. 2 It is important for the treating health care provider to understand that lichen planus may be found with other diseases of altered immunity, including ulcerative colitis, alopecia areata, vitiligo, dermatomyositis, morphea, lichen sclerosis, and myasthenia gravis.
CONCLUSION:
Patients with erosive lichen planus of the vulva and vagina often present with burning vulvar pain, dyspareunia, or postcoital bleeding. 3 The disease often progresses to scarring of the vulva, resorption of the labia minora, vaginal adhesions, and vaginal obliteration.
1,2 Typical histologic findings include hyperkeratosis, hypergranulosis, acanthosis, damage to the basal cell layer, and a bandlike dermal infiltrate of lymphocytes and plasma cells. 1 Biopsy findings of erosive lesions of the vulva and vagina, however, are more variable and often reveal a densely inflamed submucosa devoid of epithelium. 1 It should be noted that, occasionally, vulvar lesions are associated with squamous cell carcinoma.
Although the etiology of lichen planus is unknown, the immune system is thought to play a predominant role. It has been speculated that keratinocytes in lichen planus lesions possess antigens that are responsible for the immune response following some unknown event, possibly drug or virally induced. 3 The standard treatment for erosive lichen planus of the vulva and vagina has been either local or systemic corticosteroids or nonsteroidal anti-inflammatory drugs. 4 Unfortunately, recurrence is common when medical therapy is discontinued. Recently, tacrolimus ointment, an immunosuppressant, has shown some efficacy in the treatment of erosive lichen planus of the vulva and vagina. 4 We present a case in which an acellular dermal transplant graft was used successfully for vulvovaginal reconstruction following a skinning vulvectomy and simple vaginectomy in a patient with erosive vulvovaginal lichen planus.
CASE
A 61-year-old multiparous female presented with a long history of erosive lichen planus of the vulva and vagina. Her medical history was unremarkable, and her surgical history was significant for a vaginal hysterectomy. After failing a course of high-potency topical fluorinated corticosteroids, she underwent surgical excision of extensive vaginal synechiae. Estrogen cream, in conjunction with the use of a vaginal obturator, was recommended postoperatively, but the patient did not tolerate use of the obturator and the disease worsened. Two years later, the patient re-presented, having failed additional medical therapy consisting of topical tacrolimus ointment, and desired definitive surgical management. Her examination at that time was significant for worsening erosive thinning of the vulvar and vaginal mucosa, loss of the labia minora, and complete vaginal agglutination (Fig.  1A) . No oral lesions were present.
Under spinal analgesia, a skinning vulvectomy and extraperitoneal simple vaginectomy were performed. Approximately 4 mm of the distal urethra was involved with disease and was removed as part of the surgical specimen. Anterior and posterior colporrhaphies were performed in the standard fashion for pelvic organ support. Upon completion of all surgical procedures, a cystoscopy was performed and confirmed integrity of the bladder.
Two pieces of AlloDerm graft (LifeCell Corporation, the Woodlands, TX), 4 ϫ 12 cm in size and 0.0015-0.0020 inch thick, were then aseptically rehydrated in sterile saline for 5 minutes and sutured to one another around a vaginal stent as previously described for the creation of a split-thickness skin graft neovagina. 5 After assuring complete hemostasis, the graft and adjustable vaginal stent (Mentor, Minneapolis, MN) were then inserted into the potential space created by the vaginectomy. The stent was then expanded with approximately 75 mL of sterile water until good approximation of the graft to the underlying tissue was obtained. Two additional pieces of acellular dermal graft were then sutured in place over the vulvectomy site (Fig. 2) , and a pressure dressing was sutured to the vulva. There were no intraoperative complications, and the blood loss was minimal.
Postoperatively, the patient required minimal analgesia for pain control. The patient's postoperative medical management included deep vein thrombosis prophylaxis with low-molecular-weight heparin and sequential compression devices, cefazolin administered intravenously for streptococcal prophylaxis, and a constipating bowel regimen to prevent fecal contamination of the operative site. On postoperative day 7, the patient returned to the operating room for removal of the pressure dressing, packing, and vaginal stent. Granulation tissue and early signs of epithelialization were present. A vaginal mold and estrogen cream were placed in the vagina. Pathology demonstrated squamous lined tissue with scarring, granulation tissue, and fibrosis, consistent with the patient's history of erosive lichen planus.
A vaginal mold was left in place for 6 weeks and was removed and rinsed daily by the patient. By the sixth postoperative week, the vulva and vagina were fully reepithelialized. Nine months after surgery the patient continued do to well with return of sexual function (Fig. 1B) .
COMMENT
Our case demonstrates that acellular dermal graft is a suitable graft material for creation of a neovagina.
PubMed was searched for the period 1980 to August 2004 for articles in the English language indexed by the key words "vaginal lichen planus" and "vulvar lichen planus." Although the literature has described attempts at surgical management for erosive vulvovaginal lichen planus, this is the first reported case of successful surgical treatment for this condition using skin grafts. 4 Acellular dermal graft was originally developed as a graft material for use in patients with full thickness burns. 6 The graft consists of human cadaver skin that is processed in such a way that all epidermal, fibroblast, and endothelial cells are removed. This process yields an immunologically inert, dermal collagen matrix with a basement membrane complex. 6, 7 The graft is a lattice that allows fibroblast infiltration, neovascularization, and epithelialization in the absence of an inflammatory response. Since its inception, acellular dermal grafts have also been used successfully at multiple sites, including gingival grafts. 7 This case presents an alternative to the traditional split-thickness skin graft neovaginal reconstructive procedure 5 and is similar to a recently reported technique using Interceed absorbable adhesion barrier for vaginoplasty. 8 Acellular dermal graft provides a major advantage over the commonly used split-thickness skin graft in that split-thickness skin grafts require a donor site for harvesting the graft, a major source of pain postoperatively that is often refractory to traditional postoperative analgesia. 6 By using an acellular dermal graft with this patient, no donor site was needed, and the patient reported minimal pain postoperatively.
One disadvantage, however, of using an acellular dermal graft is the increased risk of contracture compared with split-thickness or full-thickness skin grafts. In general, compared with full-thickness skin grafts, splitthickness skin grafts exhibit a higher the degree of contracture. Since an acellular dermal graft acts only as a basement membrane for rapid fibroblast infiltration and migration, it theoretically has the highest risk of contracture among these grafting techniques. Because of the patient's capacious vagina and introitus, however, this was not a concern and vulvovaginal stricture was not apparent postoperatively.
Another option with this patient would have been to allow the vulva and vagina to granulate without the use of any graft material after the skinning vulvectomy and vaginectomy had been performed. Using an acellular dermal graft, however, allowed the vulva and vagina to re-epithelialize more rapidly, thereby decreasing the risk of agglutination and contracture. Our case demonstrates that an acellular dermal graft can be successfully used for vaginal and vulvar reconstruction. Antiphospholipid syndrome (APS) is an autoimmune condition characterized by a combination of autoantibodies and specific clinical features. Anticardiolipin antibodies (ACA), lupus anticoagulant (LA), and the antibodies causing false-positive serologic test for syphilis (FP-STS) are the most common. Specific associated features include thrombosis (both arterial and venous), recurrent fetal loss, and autoimmune thrombocytopenia. Liver infarction has been identified in patients with APS in the second and third trimesters of pregnancy 1,2 and after pregnancy loss. 3 This case report illustrates liver infarction occurring postpartum in a woman with known APS.
CASE
A 30-year-old woman was admitted, at 36 weeks and four days of gestation, in her second pregnancy with proteinuria and hypertension. She had a history of two deep vein thromboses (DVTs): one while taking the combined contraceptive pill and the other after a fetal death at 23 weeks of gestation. Antiphospholipid syndrome was subsequently diagnosed, after investigation of the fetal death, when the presence of IgG cardiolipin antibody and lupus anticoagulant were discovered.
In this pregnancy prophylactic aspirin (75 mg daily) was commenced at 10 weeks of gestation and enoxaparin (40 mg daily) at 14 weeks of gestation. The platelet count and anti Xa levels were monitored monthly and remained within normal limits. Ultrasonic growth and Doppler studies performed at 24, 27, 31, and 35 weeks of gestation were also normal. On admission the patient had severe proteinuria and hypertension (blood pressure ͓BP͔ 130/95mmHg). Bloods taken for full blood count, urate, and renal and liver function were all within normal limits. Labor was induced with prostaglandin pessaries followed by artificial rupture of membranes 18 hours after stopping enoxaparin, resulting in the spontaneous vaginal delivery of a healthy boy (2,360 g). Enoxaparin was recommenced two hours after delivery.
Twenty seven hours after delivery the patient developed severe right-sided chest pain, worse when supine, with an associated mild pyrexia (37.5°C) and normal oxygen saturation. Chest and abdominal examination results were unremarkable. There was no clinical evidence of DVT. Electrocardiogram, arterial blood gases, chest X-ray, C reactive protein, and c-Troponin I were all normal. The white cell count was raised at 22.7 ϫ 10 9 /L with a marked neutrophilia. The patient was anticoagulated using intravenous heparin and oral warfarin while radiological investigations were performed to exclude a pulmonary embolism. Antibiotics were also administered as pneumonia could not be discounted.
The chest pain persisted for the next two days and was not relieved by antacids, glyceryl trinitrate spray, or strong opioids. The patient's white cell count increased to 29.5 ϫ 10 9 /L, alanine transaminase to 127,296 IU/L and alkaline phosphatase to 428 IU/L. Abdominal ultrasonography and ventilation/perfusion scan were normal. A spiral computer tomography was performed to exclude a cardiothoracic lesion and results were negative for focal lung lesions, pulmonary emboli, and aortic dissection. It did, however, identify multiple peripheral liver infarcts (Fig. 1) .
The patient's chest pain resolved over the next four days with an associated drop in her serum transaminases. Intravenous heparin was stopped once international normalized ratio levels reached therapeutic levels. She was discharged home, was taking warfarin, and was referred to see an immunologist two months postpartum. It was subsequently decided that she should continue taking warfarin long-term as this was her third thromboembolic event (two DVTs and liver infarction).
COMMENT
Liver infarction during pregnancy and after pregnancy loss has been described previously in the literature. This case is interesting because the symptoms occurred shortly after delivery, after induction of labor for preeclampsia. Patients typically present with severe right upper quadrant and/or epigastric pain. There may be associated nausea and vomiting, hypothermia, [1] [2] [3] [4] or fever. Our patient had severe right-sided chest pain and a mild pyrexia, but there was no clinical evidence of infection. Interestingly, fever in pleuropulmonary disease with cardiac manifestations has been reported as a postpartum syndrome associated with antiphospholipid antibodies. 5 Serum tests usually demonstrate a marked leucocytosis with elevated transaminases and alkaline phosphatase. Associated symptoms and signs as well as serum testing for hematological and biochemical abnormalities are not specific, and making a diagnosis can be challenging. Differential diagnoses of obstetric causes include pulmonary embolism, hepatic subcapsular hemorrhage secondary to severe preeclampsia or HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome, and acute fatty liver. Nonobstetric causes include biliary tract and liver disease, thoracic aneurysm, thombotic thrombocytopenic purpura, and lung and gastrointestinal disease.
Historically, infarctions of the liver were diagnosed at autopsy. The development of therapies such as hepatic artery embolization, for the treatment of hepatic malignancies, have increased our understanding of the clinical and radiological features of liver infarction. 3 Hepatic infarction is a rare phenomenon because of the liver's dual blood supply via the hepatic artery and portal venous system. The most common causes are obstructive vascular lesions; however, it may be secondary to reduced hepatic blood flow during circulatory shock, sepsis, anesthesia, or biliary disease. 3, 4 Computed tomography scanning has proven useful in the diagnosis of liver infarction where areas of low attenuation are typically described as circumscribed and wedge shaped, most of which extend to the periphery of the liver.
Our patient has had two previous DVTs and one fetal death, increasing her risk of recurrent thromboembolism. It was reasonable to commence prophylactic low molecular weight heparin and aspirin during the antenatal period 6 although it did not prevent liver infarction. It is possible that stopping heparin therapy during labor could have increased the risk of developing thromboembolism and subsequent liver infarction. Some authorities would argue that this patient should have been fully anticoagulated during pregnancy. Heparin has the advantage over warfarin of not crossing the placenta and therefore affecting fetal well-being. 7 However, problems are associated with long-term heparin such as hemorrhage, osteoporosis, and thrombocytopenia. Warfarin, on the other hand, has potential teratogenic side effects. In addition therapeutic doses have associated complica- tions, especially hemorrhage, antenatally and during labor. The decision to start prophylactic or therapeutic doses of heparin or heparin and low dose aspirin in this situation remains with the clinician.
Our patient appeared to have appropriate management yet she still had a thromboembolic event. This demonstrates the difficulty in managing high-risk patients in a high-risk physiological state. Therefore, women who present with symptoms suspicious of a thrombolic event should be immediately fully anticoagulated to reduce the risk of additional potentially drastic sequelae. This case illustrates how thrombosis of any vasculature secondary to APS can result in potentially life-threatening complications. As the symptoms and signs associated with liver infarction can be rather nonspecific, arriving at the diagnosis is a challenge to the clinician.
BACKGROUND: Body piercing is increasing and so are its complications. We describe a case in which the female partner of an individual who had penile piercing was affected.
CASE:
A young female presented to the emergency department with the possibility of a lost/missing foreign body in the vagina. Her partner had had a "Prince Albert" type of penile piercing, which was found to be missing after sexual intercourse. Prince Albert penile piercing is a metallic bead, which is anchored to the urethral opening. On clinical examination, the bead was not found in the vagina but was seen on pelvic X-ray. A thorough sexual history resolved the mystery of the missing Prince Albert. Body piercing is increasing in practice, especially among young people. No part of the human anatomy is apparently immune to this fashion. But body piercing is not without its problems and can lead to various complications. Gynecologists should be aware of the different types of body piercing and their complications. Due consideration should also be given to the possible complications to the partner of the individual who has been genitally pierced. We describe a case in which the partner of an individual who had "Prince Albert" type penile piercing was affected. Prince Albert penile piercing is a metallic bead, the size of a shotgun pellet, which is anchored to the urethral opening. Our case stresses the importance of a proper sexual history taking, which can sometimes get ignored in emergency situations.
CASE
A 20-year-old nulliparous, psychology student presented herself to the emergency department in an anxious state, with the possibility of a foreign body in the vagina. Her partner had had a "Prince Albert" type of penile piercing. The Prince Albert, which is a metallic bead, the size of a shotgun pellet, which is anchored to the urethral opening. The penile piercing was found to be missing after sexual intercourse earlier that day. The couple thought that the bead had become undone and that it had lodged deep in the vagina.
On admission, the woman was asymptomatic. General and pelvic examinations were unremarkable. Speculum examination revealed a healthy vagina and cervix. There was no trace of the metallic bead anywhere in the vagina. Pelvic examination revealed a normal-sized anteverted uterus. There was no tenderness in the fornices. The metallic bead was not found in the vagina. Because the partner was certain that the bead could not have gone anywhere but within the vagina, an X-ray of the pelvis was arranged to resolve the mystery of the missing bead.
The X-ray result was reported as follows: "There is a 5 mm metallic density projected over the left side of the pelvis. This is likely to represent the missing penile ornament, but its exact site with regard to the uterus is impossible to express in this film" (Fig. 1) . After the X-ray report, the doctor who initially saw the patient was contemplating arranging a diagnostic laparoscopy to determine the location of the missing bead.
The couple was seen by another physician, and additional history was elicited. They were questioned closely about their sexual practice. Questions regarding anal and oral intercourse were asked in confidence. It emerged that they had had oral sex just before penetrative vaginal intercourse. The bead was probably swallowed and lodged itself in the intestine.
Because the patient was asymptomatic, she was reassured and allowed home. A repeat X-ray was arranged for the following week. The patient was asked to report if any symptoms developed in the interim. A repeat X-ray of the abdomen did not reveal any radiopaque foreign body. Because she had passed the foreign body, she was discharged with no further follow-up arranged.
COMMENTS
Body piercing is an increasingly common practice among young people. An examination of the history of body piercing reveals that such decorations are far from being an invention of the late 20th century. Indeed, piercing has occurred for thousands of years in societies throughout the world and has been adopted throughout the spectrum of social classes. The Kama Sutra, which is believed to have been written between the first and sixth centuries AD, contains references to the piercing of the penis. 1 Most of the body piercing is individually named, but the renowned piercer Jim Ward, who developed the magazine Piercing Fans International Quarterly in the late 1970s, accepted that most of the names were contrived. One of the most renowned piercings of the male genitals is the Prince Albert. However, the idea that Prince Albert wore a penis ring to tie his member down and prevent an offensive bulge in the breeches is a modern myth. 2 Prince Albert consists of a ring, piercing through the urethral meatus that exits through the ventral surface of the penis. Many owners describe this piercing as offering "an intense urethral stimulation during intercourse." The Prince Albert heals relatively quickly, in 2-4 weeks, and this may contribute to its popularity.
But this practice of body piercing is not without its problems. Concerns over the possibility of hepatitis B and C and human immunodeficiency virus (HIV) transmission from body piercing are probably well founded. 3 As with any surgical procedure that involves piercing the skin, the possibility of bleeding and infection must be considered. Other documented complications include urethral stricture, priapism, paraphimosis, and recurrent condyloma acuminatum. 4 -6 Due consideration should also be given to possible complications to the partner of the individual who has been genitally pierced. A review of some of the piercing Web sites reveals anecdotal complications in the form of trauma to the vagina or anus, teeth chipping, and choking.
Because the great majority of the ingested foreign bodies are passed spontaneously, we managed our case conservatively. "Intelligent neglect" has proven to be the best form of management. Surgical intervention is required in only about 1% cases of foreign-body ingestion, and that is mainly for perforation, and even less fre- 
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quently for hemorrhage or obstruction. 7 Seven days is the usual maximum length of time required for a foreign body to pass through the gastrointestinal tract. Serial roentgenograms help define the progress of radiopaque objects, but slow progress may indicate the need for operative intervention for the asymptomatic patient. Close observation for signs of perforation or obstruction is mandatory, and operation is required only if pain, tenderness, fever, and/or leukocytosis, signs of obstruction, or perforation prevail. 8 In our patient, a potentially hazardous operation (laparoscopy) was prevented because a proper sexual history was taken by the physician. Although sexual history taking is a part of the curricula in medical schools, many of the physicians find it hard to take a proper sexual history. Learning the skill of sexual history taking is complicated, occurs over time, and is interwoven with several complex and charged issues. 9 Therefore, we suggest that training in sexual history taking should be revisited and changes be implemented during training as a medical student and a junior doctor.
Rupture of Fetal Ductus Arteriosus Aneurysm
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BACKGROUND: Ductus arteriosus aneurysm is a rare fetal disorder.
CASE:
A 35-year-old primigravida had an uneventful antenatal course. Ultrasound examination at 30 weeks of gestation revealed hydramnios. The fetal ductus arteriosus became saccular and dilated with turbulent flow and diameter of 2.5 cm. It was located at the left upper thorax, just distal to the pulmonic valve and extended to the thoracic aorta. A ductus arteriosus aneurysm was diagnosed prenatally. Five days after diagnosis, preterm labor occurred, and dexamethasone and terbutaline were administered. Six hours after initiation of terbutaline, the fetal heart rate suddenly dropped to 90 beats per minute (bpm). A bedside ultrasound examination performed immediately showed profound bradycardia. The aneurysm became a heterogeneous hypoechoic mass with no pulsation, and the fetal heart rate suddenly disappeared. Ductus arteriosus aneurysm is a rare fetal disorder characterized by localized saccular or tubular dilation of the ductus arteriosus. Three case reports describe the prenatal detection of ductus arteriosus aneurysm [1] [2] [3] ; all were detected coincidentally during a late obstetric scan. Ductus arteriosus aneurysm is usually not related to any other extracardiac malformation, although it may rarely be associated with some specific syndromes, such as Marfan, Ehlers-Danlos, and Larsen. 2, 4 It may also be associated with connective tissue disorders, which can be progressive and place the infant at higher risk of spontaneous rupture. 5 Most affected infants have a benign course with spontaneous resolution. However, rare cases may be associated with complications such as thrombus extension into the pulmonary artery; spontaneous rupture; compression of surrounding vessels, airways, and nerves (particularly the recurrent laryngeal nerve); and asymptomatic cerebral infarction. The purpose of this report was to describe the prenatal diagnosis of large ductus arteriosus aneurysm associated with hydramnios and potential risk of rupture following terbutaline or dexamethasone administration.
CONCLUSION:

CASE
A 35-year-old pregnant woman, G1P0, had an uneventful antenatal course. However, large-for-date uterine size was detected at 30 weeks of gestation, and ultrasound examination was requested. The sonographic findings included normal fetal biometry consistent with menstrual age, hydramnios with amniotic fluid index of 30, and abnormal cardiac axis. Fetal echocardiography revealed the interventricular septum or cardiac axis parallel to the transverse axis of the thoracic cage. The 4-chamber view was structurally normal. The aortic root exited normally from the left ventricle, and the pulmonary trunk exited from the right ventricle with normal aortic and pulmonic valves. The ductus arteriosus (Figs. 1 and 2) became saccular and dilated with turbulent flow and a diameter of 2.5 cm. It was located at the left upper thorax, just distal to the pulmonic valve, and extended to the thoracic aorta. The right pulmonary artery could not be identified. The course of ascending aorta was abnormally displaced to the left side and encircled the markedly dilated ductus arteriosus. The connection of the pulmonic valve, the main pulmonary trunk, and the saccular ductus arteriosus was clearly demonstrated. The cardiac size was normal, without any other sign of hydrops fetalis. Ductus arteriosus aneurysm was prenatally diagnosed, and the patient underwent expectant management with serial ultrasound examinations.
Five days later, at 31 weeks of gestation, preterm labor occurred. Dexamethasone for fetal lung maturity and terbutaline (Bricanyl) for labor inhibition were administered. Terbutaline was started with a loading dose of 250 
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Tongsong et al Ductus Arteriosus Aneurysm OBSTETRICS & GYNECOLOGY g, and 10 g per minute was given with adjustment according to contraction. Six hours after initiation of terbutaline, fetal heart rate monitoring showed tachycardia of 165 bpm, which suddenly dropped to 90 bpm. Preparation for cesarean delivery was done immediately. A bedside ultrasound examination was performed simultaneously and showed profound bradycardia. The aneurysm became a heterogeneous hypoechoic mass with no pulsation (Fig. 3) . The fetal heart rate disappeared shortly after that. Fetal death secondary to rupture of the ductus arteriosus aneurysm was diagnosed.
Terbutaline was stopped, and a stillborn male fetus weighing 1,660 g was delivered vaginally. Postnatal autopsy confirmed the ruptured ductus arteriosus aneurysm without evidence of arterial wall pathology and no other anomalies.
COMMENT
Ductus arteriosus aneurysm is a rare congenital lesion and a potentially fatal abnormality likely to develop in the third trimester. 1 The mechanism of ductus aneurysmal formation remains uncertain. However, several theories have been proposed, such as abnormal intimal cushion formation or defective elastin in the ductus arteriosus, 1 congenital wall weakness resulting from necrosis and mucoid degeneration of the media in the ductal wall, 6 increased flow through the ductus arteriosus leading to aneurysmal formation, 2 and intrauterine ductal constriction causing poststenotic dilation of the ductus arteriosus. 7 Concomitant exposure to increased arterial pressure, which occurs in the third trimester, may also contribute. Infants with connective tissue disorders in whom there is either defective fibrillin (Marfan syndrome) or collagen (Ehlers-Danlos syndrome) would be predisposed to the development of ductus arteriosus aneurysm. 2, 4 There have been a small number of case reports of the prenatal detection of aneurysm of ductus arteriosus. [1] [2] [3] Most are asymptomatic and detected in the third trimester with spontaneous closure during 3-35 days after birth. 8 Jan et al 8 suggested that the presence of ductus arteriosus aneurysm may be a normal variant of the ductal bump and part of a normal process of spontaneous ductal closure in fullterm neonates. However, the case presented in this article should be considered fetal abnormality because it was too large to be a normal variant and it was also related to hydramnios and potential rupture. With high-resolution ultrasonography, ductus arteriosus aneurysm may be increasingly diagnosed antenatally. The finding is not always benign, and it can be associated with thrombosis and spontaneous or iatrogenic rupture.
Based on the case presented here and previous reports, prenatal diagnosis of ductus arteriosus aneurysm using fetal echocardiograms should include the following criteria: 1) ductus arteriosus becoming a tortuous and dilated vascular structure that protrudes leftward of the aortic arch; 2) the maximum diameter of ductus arteriosus aneurysm toward the aortic end, with a diameter ranging from 8 to 24 mm; and 3) swirling of blood within the aneurysm identified by color flow mapping.
In the case presented here, ductus arteriosus aneurysm was associated with hydramnios. This may be an early sign of high-output heart failure as in aneurysms or arteriovenous malformations elsewhere. This case suggests that at least some cases of ductus arteriosus aneurysm are not benign, as suggested by some authors. 8 Ductus arteriosus aneurysm may be associated with hydramnios or even potential rupture.
Because of preterm labor, tocolysis to postpone pregnancy was necessary, at least for steroid administration to accelerate lung maturity. Indomethacin, which is effective for both hydramnios and labor inhibition, may have been ideal for our case. However, it is well established that indomethacin can cause constriction of the ductus arteriosus. This may theoretically be associated with ductus arteriosus aneurysm rupture in utero, although this potential risk is currently unclear. Magnesium sulfate is less effective for inhibition of preterm labor. 9 Therefore, after counseling, we used terbutaline for tocolysis with close surveillance.
Based on the finding of rupture of ductus arteriosus aneurysm occurring during terbutaline infusion with a fetal heart rate of 165 bpm and sudden change to profound bradycardia, we speculate that, in our case, fetal tachycardia secondary to terbutaline was probably associated with rupture of the aneurysm. Our report indicates that ␤-sympathomimetics could possibly place the aneurysm at high risk for rupture. This experience suggests that the choice of tocolysis may be the agents that do not interfere with the fetal hemodynamic, such as magnesium sulfate, although these agents are less effective for labor inhibition. Extreme precaution must be taken for tocolysis. Glucocorticoids can cause mild constriction of the ductus arteriosus 4 -5 hours after the first injection. 10 It is therefore possible that dexamethasone administration in our case would have placed the ductus arteriosus aneurysm at potential risk for rupture.
Although congenital ductus arteriosus aneurysm could be a variant of normal anatomy, the potential complications cannot be completely ignored. In addition to spontaneous rupture, which is usually related to dismal outcome, 1 the case presented here documents a possible iatrogenic rupture of ductus arteriosus aneurysm with tocolysis or glucocorticoid. BACKGROUND: Uterine malignant mixed mesodermal tumor is a rare variant of uterine cancer. Data suggest that tamoxifen is involved in the pathogenesis. We report a case of a women in whom a malignant mixed mesodermal tumor was diagnosed while she was taking raloxifene, which is also a selective estrogen receptor modulator.
CASE:
A malignant mixed mesodermal tumor was diagnosed in a 64-year-old woman with a bicornuate uterus while she was taking raloxifene for osteoporosis prevention. Diagnosis had been delayed secondary to sampling of the other uterine horn. Unopposed estrogen causes an increase in endometrial glandular and stromal cell division, leading to hyperplasia and neoplasia. Uterine sarcoma is a rare type of uterine malignancy occurring in 2-4% of uterine cancers. 1 Approximately 50% of uterine sarcomas are malignant mixed mesodermal tumors, which are comprised of both epithelial and stromal elements. Malignant mixed mesodermal tumors are high grade malignancies. One theory on their histogenesis is that they develop from a stem cell common to both the epithelial and the stromal cell.
CONCLUSION:
Tamoxifen is a selective estrogen receptor modulator (SERM), which has become important in the adjuvant treatment of patients with breast cancer. Tamoxifen has also been noted to reduce the incidence of osteoporotic fractures by 19%. 2 Although tamoxifen has a low sideeffect profile, the major toxicity with its use is an increased risk of endometrial cancer. It has been reported that women taking tamoxifen have an increased risk of endometrial cancer 2-3 times higher than women taking a placebo. 3 Investigators have also noted an increased incidence of malignant mixed mesodermal tumors in patients taking tamoxifen compared with patients taking a placebo. 4 A second SERM, raloxifene, has been demonstrated to significantly decrease the risk of breast cancer. 5 Ralox-ifene was also noted to demonstrate similar skeletal benefits as tamoxifen. Recent data show that raloxifene has no proliferative effects on the endometrium. 6 There are currently no data demonstrating a link between raloxifene and uterine malignancies. We present a case of a postmenopausal woman in whom a uterine malignant mixed mesodermal tumor was diagnosed while she was taking raloxifene for osteoporosis prevention.
CASE
A 64-year-old woman with a known history of a bicornuate uterus presented to her primary obstetrician-gynecologist in October 2002 with postmenopausal bleeding. Her medical history was significant for an absent right kidney (which was diagnosed at the time of the workup for the bicornuate uterus) and increased cholesterol levels. She had been prescribed raloxifene for osteoporosis prevention approximately 1 year before the onset of symptoms and had no history of abnormal or postmenopausal bleeding. An endometrial biopsy performed at that time revealed an endometrial polyp, without evidence of hyperplasia or neoplasia. The patient had persistent symptoms and underwent transvaginal ultrasonography in March 2003, which demonstrated a bicornuate uterus. The right endometrial echo was 4 mm, whereas the left endometrial echo was 24 mm. An ultrasound-guided biopsy revealed a malignant mixed mesodermal tumor. Computed tomography of the chest, abdomen, and pelvis revealed no evidence of lymphadenopathy or metastatic disease. Her body mass index was calculated to be 22.7 kg/m 2 . The patient underwent a total abdominal hysterectomy, bilateral salpingo-oophorectomy, pelvic washings, pelvic and paraaortic lymph node dissection, and appendectomy. There was no evidence of gross upper abdominal disease at exploratory laparotomy. The uterus was bicornuate and weighed 84 g. Overall, it measured 3 cm from cervix to fundus, 5 cm from cornu to cornu, and 4.5 cm from anterior to posterior. On opening, the right endometrial cavity was atrophic in appearance, measuring 3.5 cm long, 1 cm across, and 0.1 cm thick. The left endometrial cavity measured 5 cm long, 3 cm across, and contained a polypoid mass measuring 3 ϫ 2.5 ϫ 1 cm. On section, this tumor grossly invaded the myometrium. The ovaries were atrophic.
Microscopically, the polypoid tumor in the left endometrial cavity proved to be a carcinosarcoma (malignant mixed mesodermal tumor), with a biphasic microscopic appearance. Tumor invaded 50% of the myometrial wall and showed lymphovascular invasion. Immunostains for estrogen and progesterone receptor in the tumor were negative. The endometrium in the right endometrial cavity showed only a weak estrogen effect. The cervix, fallopian tubes, ovaries, appendix, and pelvic and paraaortic lymph nodes were all negative for tumor.
The patient's hospital course was unremarkable, and she was discharged home on postoperative day 4. She has since received 45 cGy external-beam radiation, "sandwiched" between 6 cycles of ifosfamide and cisplatin (3 cycles before radiation and 3 cycles subsequent to radiation) as adjuvant therapy. She is currently without evidence of recurrent disease.
